Home/Filings/4/0001204391-07-000010
4//SEC Filing

CONNETICS CORP 4

Accession 0001204391-07-000010

CIK 0001004960operating

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 2:37 PM ET

Size

21.9 KB

Accession

0001204391-07-000010

Insider Transaction Report

Form 4
Period: 2006-12-29
VONTZ CHARLES GREGORY
President & COO
Transactions
  • Disposition to Issuer

    Option to Purchase Common Stock

    2006-12-29$11.00/sh5,000$55,0000 total
    Exercise: $6.50From: 2006-12-29Exp: 2009-12-07Common Stock (5,000 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2006-12-29$5.60/sh85,000$476,0000 total
    Exercise: $11.90From: 2006-12-29Exp: 2012-01-01Common Stock (85,000 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2006-12-29$11.00/sh103,610$1,139,7100 total
    Exercise: $6.50From: 2006-12-29Exp: 2009-12-07Common Stock (103,610 underlying)
  • Disposition to Issuer

    Common Stock, Par Value $0.001

    2006-12-29$17.50/sh26,906$470,8550 total
  • Disposition to Issuer

    Common Stock, Par Value $0.001

    2006-12-29$17.50/sh103,820$1,816,8500 total
  • Disposition to Issuer

    Option to Purchase Common Stock

    2006-12-29$12.94/sh4,771$61,7250 total
    Exercise: $4.56From: 2006-12-29Exp: 2011-01-02Common Stock (4,771 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2006-12-29$8.75/sh91,390$799,6630 total
    Exercise: $8.75From: 2006-12-29Exp: 2010-01-04Common Stock (91,390 underlying)
  • Disposition to Issuer

    Option to Purchase Common Stock

    2006-12-29$5.05/sh125,000$631,2500 total
    Exercise: $12.45From: 2006-12-29Exp: 2013-01-02Common Stock (125,000 underlying)
Footnotes (6)
  • [F1]In connection with the merger agreement between issuer and Stiefel Laboratories, shares of the Issuer's common stock were converted into the right to receive $17.50 per share in cash, without interest.
  • [F2]Immediately prior to the effective time of the merger between issuer and Stiefel Laboratories, Inc., all restrictions on these shares of restricted stock were released, and the shares became fully vested and eligible for the merger consideration in an amount equal to $17.50 multiplied by the number of shares of common stock subject to the restrictions, less any required witholding.
  • [F3]Immediately prior to the effective time of the merger between issuer and Stiefel Laboratories, the options became fully vested. In exchange for the options, the Issuer paid to the Reporting Person either (a) -0- for each grant of options if the exercise price of the options was equal to or greater than the merger consideration of $17.50, or (b) an amount equal to the excess of the merger consideration ($17.50) over the exercise price multiplied by the number of shares of common stock subject to the option, less any required witholding, if the exercise price of the option was less than the merger consideration of $17.50.
  • [F4]The stock options were granted under a Connetics Corporation stock option plan, and were 100% vesrted on the day of grant.
  • [F5]The stock options were granted under a Connetics Corporation stock option plan and, but for the merger between Issuer and Stiefel Laboratories, would have been exercisable at the rate of 1/8th on the vesting commencement date, and 1/48th thereafter.
  • [F6]The stock options were granted under a Connetics Corporation stock option plan and, but for the merger between Issuer and Stiefel Laboratories, would have been exercisable at the rate of 25% on the one year anniversary and 1/48th per month thereafter.

Issuer

CONNETICS CORP

CIK 0001004960

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001004960

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 2:37 PM ET
Size
21.9 KB